Cargando…
Retracted: The Change of Soluble Programmed Death Ligand 1 (sPD-L1) in Plasma of Small Cell Lung Cancer and Its Clinical Significance
Autor principal: | Methods in Medicine, Computational and Mathematical |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371646/ https://www.ncbi.nlm.nih.gov/pubmed/37503446 http://dx.doi.org/10.1155/2023/9831946 |
Ejemplares similares
-
Retracted: Analysis of the Role and Mechanism of ZEB1 in Regulating Cervical Carcinoma Progression via Modulating PD-1/PD-L1 Checkpoint
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retracted: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)